You are here

Eli Lilly and Company

Member Since 2006

Jacob Van Naarden

Executive Vice President, Eli Lilly and Company; President, Loxo at Lilly

Jake Van Naarden serves as executive vice president of Eli Lilly and Company and president of Loxo at Lilly. In this role, Jake oversees all aspects of oncology spanning discovery through commercial. Jake joined Lilly in 2019 when the company acquired Loxo Oncology, Inc., where he was the chief operating officer. Following the acquisition, Jake played a key role in establishing the Loxo at Lilly research and development program. In his earlier roles, Jake worked in various biotechnology investing, operational, and advisory capacities, including positions with HealthCorManagement, Aisling Capital, and Goldman Sachs. Jake received his A.B. degree in molecular biology from Princeton University.

CEO Cancer Gold Standard™

Gold Standard  Employer

Since 2011


At Lilly, our commitment to making life better goes beyond the medicines we make - it’s at the very heart of our business. We are honored to have been designated a CEO Cancer Gold Standard accredited corporation, which underscores the importance we place on the well-being of our employees. We in Lilly Oncology, continually strive to create an environment of wellness for our employees, one that provides them with the preventive care and education they need to live happy, healthy and productive lives.

— Jacob Van Naarden

Gold Standard  Task Force Participation

Task Force Member(s): Leslie M Ayres, RN, Manager Corporate Health Services; Charles Williams, Senior Director - Corporate Health Services

Life Sciences Consortium

LSC  Task Force Participation

Task Force Member(s): Susan Mahony, PhD, Senior Vice President and President, Lilly Oncology; Anwar M. Hossain, Research Scientist

Member: Anwar M. Hossain, Research Scientist

Project Data Sphere, LLC

an independent initiative of the Life Sciences Consortium

Data Provider

Since 2015

Eli Lilly and Company

Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

We were founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicines that meet real needs. More than a century later, we are passionate about building on this precedent in our continued pursuit to make life better for individuals, communities, and the world around us.

Our heritage and our values are the foundation of our promise to unite caring with discovery to make life better for people around the world.

Our mission
We make medicines that help people live longer, healthier, more active lives.

Our values
Integrity, excellence, respect for people

Our vision
We will make a significant contribution to humanity by improving global health in the 21st century.